Free Trial
→ One page of the SpaceX S-1 will move this stock overnight (From Behind the Markets) (Ad)tc pixel Free DHT.UN Stock Alerts

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$16.95 +0.15 (+0.89%)
As of 05/25/2026 03:59 PM Eastern
Compare

DHT.UN vs. BHC, CRON, THCX, TLRY, and GUD

Should you buy DRI Healthcare Trust stock or one of its competitors? MarketBeat compares DRI Healthcare Trust with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DRI Healthcare Trust include Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Tilray Brands (TLRY), and Knight Therapeutics (GUD). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does DRI Healthcare Trust compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Bausch Health Companies has a beta of 0.631102, meaning that its stock price is 37% less volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.347429, meaning that its stock price is 65% less volatile than the broader market.

DRI Healthcare Trust has lower revenue, but higher earnings than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A
DRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A

10.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

DRI Healthcare Trust has a consensus price target of C$25.50, indicating a potential upside of 50.44%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts plainly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-13.54% 120.43% 4.16%
DRI Healthcare Trust 5.02%2.06%4.22%

In the previous week, Bausch Health Companies had 9 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 12 mentions for Bausch Health Companies and 3 mentions for DRI Healthcare Trust. DRI Healthcare Trust's average media sentiment score of 1.00 beat Bausch Health Companies' score of -0.25 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Bausch Health Companies Neutral
DRI Healthcare Trust Positive

Summary

DRI Healthcare Trust beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

DRI Healthcare Trust (TSE:DHT.UN) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

DRI Healthcare Trust presently has a consensus target price of C$25.50, suggesting a potential upside of 50.44%. Cronos Group has a consensus target price of C$4.75, suggesting a potential upside of 24.67%. Given DRI Healthcare Trust's higher probable upside, equities research analysts clearly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Comparatively, 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust has a beta of 0.347429, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.11805, meaning that its stock price is 12% more volatile than the broader market.

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.00 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Cronos Group Neutral

DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of -1.29%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Cronos Group -1.29%-0.19%-3.73%

DRI Healthcare Trust has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A
Cronos GroupC$159.54M8.92-C$32.78MN/AN/A

Summary

DRI Healthcare Trust beats Cronos Group on 9 of the 13 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

DRI Healthcare Trust (TSE:DHT.UN) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

DRI Healthcare Trust presently has a consensus target price of C$25.50, indicating a potential upside of 50.44%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, equities research analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

0.6% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Hydropothecary. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Hydropothecary. DRI Healthcare Trust's average media sentiment score of 1.00 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Hydropothecary Neutral

DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Hydropothecary N/A N/A N/A

DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A
HydropothecaryN/AN/AN/AN/AN/A

Summary

DRI Healthcare Trust beats Hydropothecary on 11 of the 11 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Tilray Brands?

DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

DRI Healthcare Trust has a beta of 0.347429, meaning that its share price is 65% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its share price is 224% more volatile than the broader market.

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Tilray Brands. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Tilray Brands. DRI Healthcare Trust's average media sentiment score of 1.00 beat Tilray Brands' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Tilray Brands Neutral

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -158.75%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Tilray Brands -158.75%-88.06%-1.41%

DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A
Tilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/A

DRI Healthcare Trust currently has a consensus target price of C$25.50, suggesting a potential upside of 50.44%. Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 77.33%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.1% of Tilray Brands shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

DRI Healthcare Trust beats Tilray Brands on 10 of the 16 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of 1.10%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Knight Therapeutics1.10% 0.73% 0.51%
DRI Healthcare Trust 5.02%2.06%4.22%

Knight Therapeutics has a beta of -0.214451, meaning that its stock price is 121% less volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.347429, meaning that its stock price is 65% less volatile than the broader market.

DRI Healthcare Trust has lower revenue, but higher earnings than Knight Therapeutics. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Knight TherapeuticsC$510.45M1.61-C$30.73MC$0.06139.33
DRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A

Knight Therapeutics currently has a consensus target price of C$9.50, suggesting a potential upside of 13.64%. DRI Healthcare Trust has a consensus target price of C$25.50, suggesting a potential upside of 50.44%. Given DRI Healthcare Trust's higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Knight Therapeutics. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Knight Therapeutics. DRI Healthcare Trust's average media sentiment score of 1.00 beat Knight Therapeutics' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Knight Therapeutics Neutral
DRI Healthcare Trust Positive

23.2% of Knight Therapeutics shares are held by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are held by institutional investors. 45.6% of Knight Therapeutics shares are held by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

DRI Healthcare Trust beats Knight Therapeutics on 10 of the 15 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

Export
MetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$932.52MC$2.22BC$6.46BC$12.16B
Dividend Yield3.45%2.95%2.76%6.20%
P/E Ratio-18.835.1621.2237.64
Price / Sales5.691,770.59553.9211.68
Price / CashN/A10.1843.4982.29
Price / Book1.8210.6110.374.50
Net IncomeC$9.73MC$20.70BC$3.57BC$299.09M
7 Day Performance5.34%8.23%6.40%2.48%
1 Month Performance2.67%3.77%3.52%1.47%
1 Year Performance33.99%22.84%34.02%53.55%

DRI Healthcare Trust Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
2.6745 of 5 stars		C$16.95
+0.9%		C$25.50
+50.4%		+34.1%C$932.52MC$163.77MN/AN/A
BHC
Bausch Health Companies
0.7298 of 5 stars		C$7.55
+0.3%		N/A+26.1%C$2.82BC$10.53BN/A19,900
CRON
Cronos Group
2.4406 of 5 stars		C$3.77
-0.5%		C$4.75
+26.0%		+36.6%C$1.41BC$159.54MN/A450
THCX
Hydropothecary
N/AC$5.30
+6.6%		N/A+0.0%C$949.11MN/AN/AN/A
TLRY
Tilray Brands
1.2797 of 5 stars		C$7.33
-2.9%		C$13.30
+81.4%		+25.0%C$876.70MC$858.28MN/A2,650

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:DHT.UN) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel